← Back to Clinical Trials
Recruiting NCT05778552

NCT05778552 The Intermediate and Long-term Follow up of Home Based Pelvic Muscle Training

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05778552
Status Recruiting
Phase
Sponsor Taipei Veterans General Hospital, Taiwan
Condition Pelvic Floor Disorders
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2023-04-01
Primary Completion 2025-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Home-based pelvic muscle training devices or traditional PFMT at hospital

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2023-04-01 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

When participants present with symptoms of pelvic organ prolapse (POP) and stress urinary incontinence (SUI), the investigators will perform a comprehensive evaluation and initially provide conservative treatment. If conservative treatment fails, invasive treatment will be considered. The investigators will arrange a pelvic muscle training course two to three times a week for a duration of 1.5 months per course. However, participants may complain about the inconvenience of traffic, which may lead to discontinuation of the pelvic training course. Therefore, the investigators propose the development of a home-based pelvic muscle training device and will collaborate with information engineering specialists at Tamkang University to invent the device for home-based pelvic muscle training.

Eligibility Criteria

Inclusion Criteria: * Age \> 18-year-old, non-pregnancy, SUI, bladder capacity \> 300ml, RU\<150ml, pelvic organ prolapse Exclusion Criteria: * recurrent UTI, cancer patients, chronic pelvic pain, psychologic problems

Contact & Investigator

Central Contact

Huann-Cheng Horng

✉ hchorng@vghtpe.gov.tw

📞 886-(2) 2875-7826

Principal Investigator

Huann-Cheng Horng

PRINCIPAL INVESTIGATOR

Taipei Veterans General Hospital, Taiwan

Frequently Asked Questions

Who can join the NCT05778552 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Pelvic Floor Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05778552 currently recruiting?

Yes, NCT05778552 is actively recruiting participants. Contact the research team at hchorng@vghtpe.gov.tw for enrollment information.

Where is the NCT05778552 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT05778552 clinical trial?

NCT05778552 is sponsored by Taipei Veterans General Hospital, Taiwan. The principal investigator is Huann-Cheng Horng at Taipei Veterans General Hospital, Taiwan. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology